J&J chalks up win in second DePuy ASR hip trial 
Published: May 1, 2013
Tags: ASR hip implants, DePuy hip litigation, DePuy Orthopaedics, Johnson & Johnson, product liability
A Chicago jury has decided that Johnson & Johnson’s DePuy Orthopaedics unit is not liable for the failure of a metal-on-metal hip implant that failed three years after an Illinois woman’s hip-replacement surgery.
$8.3 million verdict gives lawyers first peek at metal hip litigation
By:
Sylvia Hsieh
Published: March 28, 2013
Tags: DePuy, hip replacement, Johnson & Johnson, product liability
A jury awarded $8.3 million in the first case to go to trial over metal-on-metal hip replacement implants, providing a sneak preview of what’s to come in mass tort litigation over Johnson & Johnson’s DePuy ASR XL product.
Jury awards $11 million in first bellwether vaginal mesh trial
By:
Sylvia Hsieh
Published: March 7, 2013
Tags: American Medical Systems, Boston Scientific, C.R. Bard, Ethicon, Johnson & Johnson, medical device litigation, medical devices, multidistrict litigation, Prolift, vaginal mesh
In the first bellwether trial in the litigation over vaginal mesh products, a New Jersey jury awarded a 47-year-old woman $11 million in compensatory and punitive damages.
Mass. jury awards $63M for child’s reaction to Motrin
By:
Correy Stephenson
Published: March 1, 2013
Tags: Children’s Motrin, consumer protection, drug litigation, failure to warn, FDA, Food and Drug Administration, Johnson & Johnson, Motrin, preemption, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
A Massachusetts jury awarded $63 million to a teenaged girl and her parents after the girl suffered an adverse reaction to Children’s Motrin that left her scarred and blind, with permanent brain and lung damage.
And the award may increase.
Former dancer withdraws Johnson & Johnson hip-replacement lawsuit
By:
Kristi Tousignant
Published: January 9, 2013
Tags: DePuy, DePuy hip litigation, DePuy Orthopaedics, hip replacement litigation, Johnson & Johnson
A former dancer has withdrawn her claim against Johnson & Johnson over faulty hip replacements on the same day the trial was to start.
J&J settles with 845 Levaquin plaintiffs over tendon damage
Published: November 15, 2012
Tags: drug litigation, FDA, Food and Drug Administration, Johnson & Johnson, Levaquin, MDL, multidistrict litigation, Ortho-McNeil Pharmaceutical, product liability
Drug maker Johnson & Johnson has settled approximately 845 product liability suits brought by individuals who claim they suffered tendon damage as a result of taking the antibiotic Levaquin.
J&J unit settles state Risperdal claims for $181M
Published: September 5, 2012
Tags: anti-psychotic drugs, consumer protection, FDA, Food and Drug Administration, Johnson & Johnson, off-label uses, Risperdal
Johnson & Johnson has agreed to pay a record $181 million to settle claims brought by New York and 36 other states that the company’s Janssen Pharmaceuticals unit improperly marketed Risperdal and other anti-psychotic drugs for “off-label” uses.
Reglan most litigated drug of 2011, latest ranking says
Published: June 7, 2012
Tags: Accutane, adverse events, Avandia, Bayer, Chantix, Coumadin, drug litigation, FDA, Food and Drug Administration, GlaxoSmithKline, Hoffman-LaRoche, Institute for Safe Medication Practices, Johnson & Johnson, Levaquin, Pfizer, Pradaxa, prescription drugs, Reglan, Wyeth, Yasmin, Yaz
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.
Some birth control associated with increased blood clot risk
Published: May 18, 2012
Tags: birth control, birth control litigation, birth control patch, blood clots, drug litigation, Johnson & Johnson, Merck, Nuvaring, Ortho-Evra, product liability
Women who use birth control patches like Ortho-Evra or contraceptive vaginal rings like NuvaRing have a heightened risk of blood clots, a new medical study has found.
Doctor wins $482 million patent infringement verdict
By:
Kimberly Atkins
Published: January 17, 2012
Tags: Johnson & Johnson, patent, patent infringement, stent, Top Ten Jury Verdicts, Top Ten Jury Verdicts of 2011
Plaintiff's attorney Paul Taskier
A Texas jury awarded $482 million to a radiologist on his claim that a medical stent manufacturer willfully infringed his patent.
